Methoden vergelijken
Bekijk de geselecteerde methoden naast elkaar; rijen die verschillen zijn gemarkeerd.
| PopulatiPharmacodynamische Modellering× | Schild-analyse× | |
|---|---|---|
| Vakgebied | Farmacologie | Farmacologie |
| Familie | Process / pipeline | Process / pipeline |
| Jaar van ontstaan≠ | 1992 | 1947 |
| Grondlegger≠ | Lewis Sheiner and Stephen Roush | Henry Schild |
| Type≠ | dose-response modeling | antagonism quantification |
| Oorspronkelijke bron≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Journal of Physiology, 106(3), 337-357. DOI ↗ |
| Aliassen≠ | PopPD, population PD, hierarchical PD modeling | Schild plot, pA2 |
| Verwant | 3 | 3 |
| Samenvatting≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Schild analysis is a quantitative method for characterizing competitive receptor antagonism developed by Henry Schild in 1947. It uses dose-response curves in the presence and absence of antagonist to estimate the antagonist affinity constant (pA2), enabling standardized comparison of antagonist potency across drugs and experimental systems. |
| ScholarGateGegevensset ↗ |
|
|